EGFP-encoding Oncolytic Herpes Simplex Virus 1 (ΔICP27), CMV-EGFP(Cat#: RepOV-0002XY)
DatasheetThis product is a EGFP encoding oncolytic herpes simplex virus, which is based on HSV-1 with ICP27 deleted. ICP27 is highly cytotoxic probably due to its secondary role of preventing the splicing of pre-mRNAs in favour of translation from the mainly unspliced hepes RNAs. Deletion of ICP27 might produce a safer and less cytotoxic system when combined with other oncolytic-rendered modifications. This product can be used in oncolytic virotherapy research and further recombinant HSV construction.
Specifications | |
|---|---|
| Family | Herpesviridae |
| Species | Herpes simplex virus |
| Serotype | Herpes simplex virus 1 |
| Backbone | HSV-1 (ΔICP27) |
| Backbone Background | Herpes simplex virus 1 and 2 (HSV-1 and HSV-2), also known as human herpesvirus 1 and 2 (HHV-1 and HHV-2), are two members of the human Herpesviridae family, a set of viruses that produce viral infections in the majority of humans. Modified Herpes simplex virus is considered as a potential therapy for cancer and has been extensively clinically tested to assess its oncolytic ability. |
| Gene Modification | ΔICP27 |
| Promoter | CMV |
| Transgene | EGFP |
| Type of Transgene | Reporter gene |
| Related Target/Protein | Enhanced green fluorescent protein |
| Capsid Modification | None |
| Titer | >1*10^8 PFU |
| Related Diseases | Tumor |
Transgene | |
|---|---|
| Alternative Names | EGFP, egfp, enhanced green fluorescent protein |
| Gene ID | 20473140 |
Information | |
|---|---|
| Introduction | EGFP, derived from Aequorea victoria, is a unique GFP variant which contains chromophore mutations that make the protein 35 times brighter than wild-type GFP, and is codon-optimized for higher expression in mammalian cells. These changes in the GFP coding sequence provide an enhanced GFP (EGFP) that greatly increases the sensitivity of the reporter protein. |
Customer Reviews and Q&As |
|---|
|
There are currently no customer reviews or questions for EGFP-encoding Oncolytic Herpes Simplex Virus 1 (ΔICP27), CMV-EGFP (RepOV-0002XY). Click the button below to contact us or submit your feedback about this product. |
All products and services are for Research Use Only. Not For Clinical Use.
Other products
- Dsred-encoding Oncolytic Herpes Simplex Virus 1 (ΔΔICP0), hTERT-Dsred (CAT#: RepOV-0049XY)
- IL-15-expressing Oncolytic Herpes Simplex Virus 1 (ΔICP27), hTERT-IL-15 (CAT#: CyOV-0081XY)
- IL-15-expressing Oncolytic Herpes Simplex Virus 1 (ΔICP6, ΔΔICP34.5), SV40-IL-15 (CAT#: CyOV-0249XY)
- IL-4-expressing Oncolytic Herpes Simplex Virus 1 (ΔICP27), IE4/5-IL-4 (CAT#: CyOV-0154XY)
- hTNFα-expressing Oncolytic Herpes Simplex Virus 1 (ΔΔICP0), SV40-hTNFα (CAT#: CyOV-0257XY)
- GFP-encoding Oncolytic Herpes Simplex Virus 1 (ΔΔICP34.5, ΔΔICP47), SV40-GFP (CAT#: RepOV-0117XY)
- ING4-expressing Oncolytic Herpes Simplex Virus 1 (ΔΔICP0), hTERT-ING4 (CAT#: CyOV-0118XY)
- CCL2-expressing Oncolytic Herpes Simplex Virus 2 (ΔICP10PK), SV40-CCL2 (CAT#: CyOV-0366XY)
PRODUCTS
Online Inquiry